| Q68452905 | Biochemical definition of the mucopolysaccharidoses |
| Q54433717 | Characterization of urinary peptoglycans in Morquio's disease. |
| Q39894675 | Differentiation of connective tissues. |
| Q72223143 | Epimerization of D-glucuronic acid to L-iduronic acid by deamination of heparins |
| Q42154353 | Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells |
| Q36384007 | Hurler's syndrome: biosynthesis of acid mucopolysaccharides in tissue culture |
| Q93800237 | Increased urinary excretion of chondroitin sulfate A and C in Hunter's syndrome |
| Q39735866 | Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopoly-saccharidoses |
| Q35920065 | Ocular correlates of inborn metabolic defects |
| Q72281633 | Stability of the biological activities of heparins to mild acid treatments |
| Q34272120 | Study of the Hurler syndrome using cell culture: definition of the biochemical phenotype and the effects of ascorbic acid on the mutant cell |
| Q33562639 | The structure of acid mucopolysaccharides produced by Hurler fibroblasts in tissue culture |
| Q36540186 | Urinary excretion of glycosaminoglycans in the various forms of gargoylism |